Orthopaedic Management of Gout

J Am Acad Orthop Surg Glob Res Rev. 2022 Nov 8;6(11):e22.00216. doi: 10.5435/JAAOSGlobal-D-22-00216. eCollection 2022 Nov 1.

Abstract

Gout is characterized by the deposition of monosodium urate crystals in patients with chronically elevated blood levels of uric acid. It is the most common form of inflammatory arthritis in the United States and is often comorbid with hypertension, obesity, and chronic kidney disease. Initial presentation is usually an acutely warm, swollen joint, most commonly the first metatarsophalangeal joint, but a variety of locations may be affected. The main treatment for gout is medical management of acute inflammation and chronic uric acid levels, but surgical treatment may be indicated in cases of damage to the surrounding soft tissue, concomitant septic arthritis, symptomatic cartilage loss, or neurologic deficits. Based on the literature to date, gout does not seem to independently affect outcomes after total hip, knee, and ankle arthroplasty, but associated comorbidities affecting outcomes in these patients should be considered.

MeSH terms

  • Cartilage
  • Gout* / complications
  • Gout* / surgery
  • Humans
  • Knee Joint
  • Orthopedics*
  • Uric Acid

Substances

  • Uric Acid